These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32194244)

  • 21. Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?
    Gönczi M; Papp R; Kovács M; Seprényi G; Végh A
    Br J Pharmacol; 2009 Mar; 156(5):786-93. PubMed ID: 19239476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral effects of sinomenine in murine models of anxiety.
    Chen SW; Mi XJ; Wang R; Wang WJ; Kong WX; Zhang YJ; Li YL
    Life Sci; 2005 Dec; 78(3):232-8. PubMed ID: 16111714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety.
    Volke V; Soosaar A; Kõks S; Bourin M; Männistö PT; Vasar E
    Psychopharmacology (Berl); 1997 Jun; 131(4):399-405. PubMed ID: 9226743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of olanzapine on anxiety-related behaviour in male and female rats assessed after 21-24 and 42-45 days of chronic treatment.
    Lockington MR; Hughes RN
    Behav Pharmacol; 2021 Apr; 32(2&3):194-211. PubMed ID: 33229894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nitric oxide-dependent pathways in ethanol-induced anxiolytic effects in rats.
    Ferreira VM; Valenzuela CF; Morato GS
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1898-904. PubMed ID: 10630608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiety- and activity-related effects of paracetamol on healthy and neuropathic rats.
    Chen Z; Wei H; Pertovaara A; Wang J; Carlson S
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.
    Gong MF; Wen RT; Xu Y; Pan JC; Fei N; Zhou YM; Xu JP; Liang JH; Zhang HT
    Psychopharmacology (Berl); 2017 Oct; 234(20):3143-3151. PubMed ID: 28748375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual effect of nitric oxide donor on adjuvant arthritis.
    Gomaa AA; Elshenawy MM; Afifi NA; Mohammed EA; Thabit RH
    Int Immunopharmacol; 2009 Apr; 9(4):439-47. PubMed ID: 19193354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prior foot shock stress and Δ
    Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety.
    Pitsikas N; Boultadakis A; Georgiadou G; Tarantilis PA; Sakellaridis N
    Phytomedicine; 2008 Dec; 15(12):1135-9. PubMed ID: 18693098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the open-field and light/dark tests.
    Heredia L; Torrente M; Colomina MT; Domingo JL
    J Pharmacol Toxicol Methods; 2014; 69(2):108-14. PubMed ID: 24374104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of chlordiazepoxide on measures of activity and anxiety in Swiss-Webster mice in the triple test.
    Hussin AT; Fraser LM; Ramos A; Brown RE
    Neuropharmacology; 2012 Oct; 63(5):883-9. PubMed ID: 22750080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia.
    Nogami A; Sakata Y; Uchida N; Yamaguchi K; Kawasaki C; Shindo T; Kubota K; Katsurabayashi S; Takasaki K; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
    J Nat Med; 2011 Apr; 65(2):275-81. PubMed ID: 21152992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on the mechanism by which sodium nitroprusside, a nitric oxide donor, applied to the anteroventral third ventricular region provokes facilitation of vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H
    Brain Res; 2003 Apr; 968(1):35-43. PubMed ID: 12644262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis.
    Gomaa A; Elshenawy M; Afifi N; Mohammed E; Thabit R
    Int Immunopharmacol; 2010 Nov; 10(11):1406-14. PubMed ID: 20800711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of sodium nitroprusside "NO-donor" on psychotropic activity of angiotensin II.
    Wiśniewski K; Hoły Z
    J Physiol Pharmacol; 1995 Jun; 46(2):141-50. PubMed ID: 7670123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in absorption and excretion of rhodamine 123 by sodium nitroprusside.
    Takizawa Y; Kitazato T; Ishizaka H; Kamiya N; Ito Y; Kishimoto H; Tomita M; Hayashi M
    Int J Pharm; 2013 Jun; 450(1-2):31-5. PubMed ID: 23618962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.